Study on Sintilimab in Stage IV High Risk Neuroblastoma
Clinical trial NCT04412408 · UNKNOWN
Trial details
- NCT number
- NCT04412408
- Sponsor
- Shanghai Children's Medical Center
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.